Constipation and diarrhea as well as bowel incontinence can be indicators of pelvic floor dysfunction and thus these types of drugs could exacerbate these existing symptoms
Semaglutide safety considerations every Brello user should understand Safety is not something you can outsource entirely to your provider, especially with a lighter-touch platform like Brello
Depending on the clinical picture, that typically includes: Relevant baseline bloodwork before starting IGF-1 dynamics where appropriate, so the response can be tracked rather than assumed Glucose and metabolic markers where relevant Follow-up adjustments based on results, tolerability, and goals A clear plan for duration and review rather than indefinite open-ended use This is also why CJC-1295 and Ipamorelin are often discussed alongside related options like Tesamorelin for visceral fat and metabolic goals
In addition to its diabetes management benefits, Semaglutide GLP-1 has garnered attention for its potential in weight management
FDA released results of its testing of nearly 200 samples of rice and rice products, finding appreciable levels in many products, although the amounts in only a few exceed the cancer-warning threshold of the State of California (10 mcg per daily serving)